Paper on Economic consequences of migraine in Sweden, and the cost-effectiveness of Botox for chronic migraine in Sweden and Norway’, co-authored by Quantify, has been published in JHP
The paper ‘Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway’ co-authored by Quantify’s Fredrik Borgström, Amanda Hansson-Hedblom and Isabelle Axelsson, has been published in the Journal of […]
The paper “Association of Skin Psoriasis and Somatic Comorbidity With the Development of Psychiatric Illness in a Nationwide Swedish Study” by Quantify’s Kirk Geale and coauthors has been published in JAMA Dermatology. 


